Follow-up of physical tests in treatment and non-treatment groups.

Table 2: Follow-up of physical tests in treatment and non-treatment groups.

Supplemented group (SG)				Non-supplemented group (NG)
Variable	CTSG (n = 48)	ATSG (n = 67)	MFSG (n = 51)	CT (n = 52)	AT (n = 79)	MF (n = 48)	Statistical analysis	F	P
Functional tests
FRT_A	21.90 ± 5.84	24.13 ± 5.80	25.63 ± 5.96	23.54 ± 5.81	23.00 ± 6.44	26.30 ± 6.22	Effect time-vitamin	1.49	0.30
FRT_B	31.39 ± 7.31	30.24 ± 6.39	33.18 ± 7.46	30.01 ± 6.82	31.19 ± 6.46	32.28 ± 6.17	Interaction of 25 (OH)D	2.13	0.07
TUG_A	8.18 ± 1.65	7.42 ± 1.36	6.76 ± 0.85	8.32 ± 1.48	7.00 ± 1.08	6.52 ± 1.26	Effect time-vitamin	0.12	0.66
TUG_B	7.47 ± 0.97^^	7.23 ± 1.39	6.61 ± 1.16^¤	7.98 ± 1.19	6.85 ± 0.98^¤¤	6.51 ± 1.24	Interaction of 25 (OH)D	0.82	0.05^*
UB_A	20.83 ± 9.07	19.09 ± 10.50	24.86 ± 8.20	17.06 ± 11.06	22.21 ± 10.23	27.18 ± 7.09	Effect time-vitamin	0.03	0.33
UB_B	21.40 ± 10.55	21.10 ± 9.06	25.76 ± 7.81^¤	21.34 ± 9.61	22.44 ± 8.83	27.81 ± 6.83^¤§	Interaction of 25(OH)D	1.88	0.03^*
HS_A	12.27 ± 1.65	12.37 ± 3.15	12.65 ± 2.46	12.89 ± 2.23	12.09 ± 2.11	12.14 ± 2.73	Effect time-vitamin	1.22	0.96
HS_B	12.36 ± 1.18	12.46 ± 1.14	13.43 ± 1.53^¤§	12.86 ± 1.17	12.44 ± 1.48	12.68 ± 1.49	Interaction of 25 (OH)D	1.63	< 0.001^*
CS_A	11.85 ± 2.95	13.31 ± 2.91	14.37 ± 4.13	10.82 ± 2.16	14.03 ± 2.74	14.93 ± 2.80	Effect time-vitamin	1.32	0.55
CS_B	12.00 ± 2.19	13.92 ± 3.83^¤¤	14.95 ± 3.58^¤	11.95 ± 2.21	14.86 ± 4.17^¤¤	15.58 ± 3.40^¤	Interaction of 25(OH)D	0.12	0.04^*
2MST_A	69.83 ± 18.43	78.25 ± 14.81	81.93 ± 16.84	72.06 ± 12.36	80.47 ± 15.52	88.71 ± 15.50	Effect time-vitamin	4.26	0.02^*
2MST_B	74.50 ± 12.80	81.65 ± 18.30^¤¤	82.45 ± 12.71^¤§	79.85 ± 17.51	89.13 ± 15.39^¤¤	92.66 ± 16.62^¤	Interaction of 25 (OH)D	0.35	0.02^*